NIH Guide + NIH RePORTER
Open NIH NOFOs: Due Dates, Institutes & Funded Projects
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 19, 2026Editorial standards
NIH has 369 open notices of funding opportunity. The NIH Guide spreads each one across its own page, participation and due-date notices, and NOSIs. Each page here puts them together, and adds how many projects NIH actually funded under that NOFO.
Open now
343
Accepting applications
Opening soon
26
Posted, open date ahead
Due in 30 days
45
Next due date by Nov 22, 2026
With funding history
305
Funded projects under it or its predecessor
Due in the next 30 days
- PAR-27-078NIA · R15Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)Due Oct 25, 2026 · in 2 days
- PAR-25-352NIMH · U01National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)Due Oct 25, 2026 · in 2 days
- PAR-25-353NIMH · U19National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)Due Oct 25, 2026 · in 2 days
- PAR-25-298NIDCR · R15Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)Due Oct 25, 2026 · in 2 days
- PAR-25-134NIGMS · R15Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)Due Oct 25, 2026 · in 2 days
- PAR-25-148NICHD · R15Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)Due Oct 25, 2026 · in 2 days
- PAR-25-103NCI · U34Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)Due Oct 25, 2026 · in 2 days
- PAR-25-104NCI · R34Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)Due Oct 25, 2026 · in 2 days
- RFA-AT-25-003NCCIH · R15HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)Due Oct 27, 2026 · in 4 days
- PAR-27-045NCCIH · R61, R33HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)Due Oct 30, 2026 · in 7 days
35 more in the full list below, sorted by next due date.
Newly posted
- PAR-28-090NIAID · P30Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)Posted Oct 16, 2026
- RFA-LM-28-001NLM · T15NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)Posted Oct 16, 2026
- PAR-28-091NCCIH · R33Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)Posted Oct 15, 2026
- RFA-AA-28-001NIAAA · P50Specialized Alcohol Research Centers (P50 Clinical trial Optional)Posted Oct 15, 2026
- RFA-CA-28-004NCI · U24Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)Posted Oct 15, 2026
- RFA-DK-27-122NIDDK · U01Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)Posted Oct 15, 2026
- PA-27-061OD · P01NIH Research Program Projects (Parent P01 Clinical Trial Optional)Posted Oct 14, 2026
- PAR-27-003NIGMS · RM1Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)Posted Oct 14, 2026
All NIH NOFOs
Search by NOFO number, title words, institute, or activity code. Filters stay in the address bar, so a filtered list can be bookmarked or shared.
369 NOFOs open or opening soon
| NOFO | Next due | Codes | Funded projects | Expires |
|---|---|---|---|---|
| PAR-27-078 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR · NIA + 11 more · R15 | Oct 25, 2026 | R15 | 16* | Oct 26, 2027 |
| PAR-25-352 National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional) PAR · NIMH + 1 more · U01 | Oct 25, 2026 | U01 | 1* | Oct 26, 2027 |
| PAR-25-353 National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional) PAR · NIMH + 1 more · U19 | Oct 25, 2026 | U19 | — | Oct 26, 2027 |
| PAR-25-298 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR · NIDCR + 18 more · R15 | Oct 25, 2026 | R15 | 29 | Jan 8, 2028 |
| PAR-25-134 Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR · NIGMS + 21 more · R15 | Oct 25, 2026 | R15 | 177 | Jan 8, 2028 |
| PAR-25-148 Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR · NICHD + 10 more · R15 | Oct 25, 2026 | R15 | 5 | Jan 8, 2028 |
| PAR-25-103 Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) PAR · NCI + 1 more · U34 | Oct 25, 2026 | U34 | 2 | Oct 26, 2027 |
| PAR-25-104 Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) PAR · NCI + 1 more · R34 | Oct 25, 2026 | R34 | 12 | Oct 26, 2027 |
| RFA-AT-25-003 HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) RFA · NCCIH + 6 more · R15 | Oct 27, 2026 | R15 | 2 | Nov 24, 2026 |
| PAR-27-045 HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) PAR · NCCIH + 6 more · R61, R33 | Oct 30, 2026 | R61, R33 | — | Oct 31, 2026 |
| RFA-HG-27-011 GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed) RFA · NHGRI + 1 more · U01 | Oct 30, 2026 | U01 | — | Oct 31, 2026 |
| RFA-HG-27-012 GREGoRi Technology Integration Center (U01, Clinical Trials Optional) RFA · NHGRI + 1 more · U01 | Oct 30, 2026 | U01 | — | Oct 31, 2026 |
| RFA-HG-27-013 GREGoRi Innovation Projects (U01 Clinical Trial Optional) RFA · NHGRI + 1 more · U01 | Oct 30, 2026 | U01 | — | Oct 31, 2026 |
| PAR-27-053 Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) PAR · NIDA + 1 more · R61, R33 | Nov 2, 2026 | R61, R33 | — | Jun 17, 2028 |
| PAR-24-279 Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR · NIAMS + 1 more · R61 | Nov 2, 2026 | R61 | 3 | Nov 3, 2026 |
| PAR-24-280 Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR · NIAMS + 1 more · R01 | Nov 2, 2026 | R01 | 3 | Nov 3, 2026 |
| PAR-25-141 NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR · NIAMS + 1 more · UG3, UH3 | Nov 2, 2026 | UG3, UH3 | 5 | Mar 5, 2027 |
| PAR-25-437 Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed) PAR · ECHO + 1 more · X01 | Nov 4, 2026 | X01 | — | Mar 2, 2028 |
| PAR-25-149 Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required) PAR · NINDS + 1 more · U01 | Nov 5, 2026 | U01 | 2 | Nov 6, 2027 |
| PAR-27-076 Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) PAR · NIH + 15 more · SI2, R00 | Nov 6, 2026 | SI2, R00 | — | Jul 8, 2028 |
| RFA-DK-27-125 Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) RFA · NIDDK + 1 more · U01 | Nov 6, 2026 | U01 | 3* | Nov 7, 2026 |
| RFA-HL-27-010 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) RFA · NHLBI + 2 more · K38 | Nov 9, 2026 | K38 | 15* | Oct 14, 2028 |
| RFA-MH-27-125 Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) RFA · NIMH + 2 more · R21, R33 | Nov 9, 2026 | R21, R33 | — | Oct 29, 2027 |
| RFA-AI-27-014 Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed) RFA · NIAID + 5 more · U01 | Nov 9, 2026 | U01 | — | Oct 10, 2028 |
| PAR-27-065 NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required) PAR · NINDS + 1 more · UG3, UH3 | Nov 9, 2026 | UG3, UH3 | 5* | Mar 10, 2029 |
| RFA-DK-27-112 Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) RFA · NIDDK + 1 more · U01 | Nov 9, 2026 | U01 | 1* | Nov 10, 2026 |
| RFA-DK-27-139 Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) RFA · NIDDK + 1 more · U01 | Nov 9, 2026 | U01 | 1* | Nov 10, 2026 |
| PAR-25-062 Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required) PAR · NIDCR + 1 more · UH3 | Nov 9, 2026 | UH3 | 2 | Jan 7, 2028 |
| RFA-RM-27-024 Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed) RFA · RMOD + 3 more · R03 | Nov 10, 2026 | R03 | 6* | Nov 11, 2026 |
| RFA-AI-27-018 Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA · NIAID + 17 more · R61, R33 | Nov 10, 2026 | R61, R33 | — | Jun 21, 2029 |
| RFA-OD-27-009 Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) RFA · OD + 4 more · SB0 | Nov 10, 2026 | SB0 | 5* | Nov 11, 2026 |
| PAR-27-096 Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) PAR · NIA + 3 more · R03 | Nov 10, 2026 | R03 | 13* | Jul 17, 2028 |
| PAR-27-112 Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed) PAR · NIA + 1 more · K76 | Nov 10, 2026 | K76 | 10* | Jun 13, 2028 |
| RFA-AG-27-010 Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) RFA · NIA + 1 more · U24 | Nov 10, 2026 | U24 | — | Nov 11, 2026 |
| RFA-AI-27-002 Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) RFA · NIAID + 1 more · UM1 | Nov 10, 2026 | UM1 | — | Nov 11, 2026 |
| RFA-AI-27-005 Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) RFA · NIAID + 1 more · UM1 | Nov 10, 2026 | UM1 | 1* | Nov 11, 2026 |
| RFA-CA-27-001 Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) RFA · NCI + 1 more · R61 | Nov 10, 2026 | R61 | 11* | Nov 11, 2026 |
| RFA-CA-27-002 Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA · NCI + 1 more · R33 | Nov 10, 2026 | R33 | 10* | Nov 11, 2026 |
| RFA-NS-26-001 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) RFA · NINDS + 2 more · U01 | Nov 10, 2026 | U01 | 1 | Nov 11, 2026 |
| PAR-25-311 Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) PAR · NICHD + 1 more · UG3, UH3 | Nov 13, 2026 | UG3, UH3 | 2 | Nov 16, 2027 |
| PAR-25-336 Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) PAR · NCI + 1 more · R01 | Nov 16, 2026 | R01 | 3 | Nov 16, 2027 |
| RFA-DK-27-122 Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) RFA · NIDDK + 1 more · U01 | Nov 17, 2026 | U01 | — | Nov 18, 2026 |
| PAR-27-003 Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) PAR · NIGMS + 12 more · RM1 | Nov 17, 2026 | RM1 | — | Sep 27, 2029 |
| RFA-DA-26-034 Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) RFA · NIDA + 2 more · R01 | Nov 18, 2026 | R01 | 6 | Nov 19, 2027 |
| PA-27-061 NIH Research Program Projects (Parent P01 Clinical Trial Optional) PA · OD + 11 more · P01 | Nov 20, 2026 | P01 | — | May 26, 2029 |
| RFA-RM-27-007 Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) RFA · RMOD + 3 more · UG3, UH3 | Nov 23, 2026 | UG3, UH3 | — | Nov 24, 2026 |
| RFA-RM-27-016 Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) RFA · RMOD + 3 more · UM1 | Nov 23, 2026 | UM1 | — | Nov 24, 2026 |
| RFA-RM-27-025 Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) RFA · RMOD + 3 more · UM1 | Nov 23, 2026 | UM1 | — | Nov 24, 2026 |
| RFA-OD-27-008 Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) RFA · OD + 5 more · Opens soon · F32 | Dec 2, 2026 | F32 | 1* | Dec 3, 2026 |
| RFA-DA-26-055 Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) RFA · NIDA + 1 more · R01 | Dec 3, 2026 | R01 | 10 | Dec 4, 2027 |
* Funded projects under the NOFO it reissues; the new number has no awards yet.
By lead institute
- NCI · National Cancer Institute49
- NIH36
- NIMH · National Institute of Mental Health31
- NIGMS · National Institute of General Medical Sciences23
- NIDA · National Institute on Drug Abuse22
- NINDS · National Institute of Neurological Disorders and Stroke21
- NHLBI · National Heart, Lung, and Blood Institute19
- OD · NIH Office of the Director17
- NIA · National Institute on Aging14
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development14
- NHGRI · National Human Genome Research Institute13
- NCCIH · National Center for Complementary and Integrative Health12
- NIDCD · National Institute on Deafness and Other Communication Disorders12
- NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases12
- NIAID · National Institute of Allergy and Infectious Diseases11
- NCATS · National Center for Advancing Translational Sciences10
- NIDCR · National Institute of Dental and Craniofacial Research10
- NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases7
- NIMHD · National Institute on Minority Health and Health Disparities5
- NLM · National Library of Medicine5
NIH NOFO questions
What is an NIH NOFO?
A Notice of Funding Opportunity (NOFO, formerly FOA) is the announcement NIH publishes in the NIH Guide for Grants and Contracts to invite applications. It sets the activity code, participating institutes, eligibility, budget, due dates, and review criteria. Every NIH grant application is submitted under a NOFO number such as PA-25-301.
What is the difference between a PA, PAR, and RFA?
A PA (Program Announcement) is an ongoing invitation, usually with standard due dates; parent announcements such as the parent R01 are PAs. A PAR is a program announcement with special receipt, referral, or review, often with its own due dates and a dedicated review panel. An RFA (Request for Applications) is a one-time solicitation with set-aside funds and usually a single due date.
Why does one NOFO have so many notices?
After posting, NIH changes a NOFO through separate notices in the NIH Guide: another institute joining (a participation notice), due-date changes, early expiration, or policy updates. Notices of Special Interest (NOSIs) are attached separately to signal topics an institute wants to fund through it. Each GotGrant NOFO page lists the related notices and active NOSIs together.
How are funded projects counted?
Funded projects come from NIH RePORTER, which records the NOFO number every award was made under. GotGrant counts distinct projects and award dollars for FY2022–FY2026. A new NOFO that reissues an older one shows the older NOFO's funding until awards appear under the new number.
How current is this list?
The NOFO list, notices, and NOSIs are refreshed from the NIH Guide every week, most recently on October 19, 2026. Funding counts from NIH RePORTER are refreshed every four weeks, most recently on October 16, 2026. Open or expired status and next due dates are recalculated daily. NOFOs posted after a refresh appear at the next one, so always confirm details in the NIH Guide before applying.
New to NIH funding? Start with the NIH funding guide or how to find NIH funding opportunities.